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Abstract: Prebiotic supplements are used to promote gastrointestinal health by stimulating beneficial
bacteria. The aim of this study was to compare the potential prebiotic effects of fructans with
increasing degrees of polymerization, namely fructooligosaccharides (FOS) and inulins with a low
and high polymerization degree (LPDI and HPDI, respectively), using an ex vivo fermentation system
to simulate the colonic environment. The system was inoculated with pooled feces from three healthy
donors with the same baseline enterotype. Changes in microbiota composition were measured by 16S
metagenomic sequencing after 2, 7, and 14 days of fermentation, and acid production was measured
throughout the experiment. Alpha-diversity decreased upon inoculation of the ex vivo fermentation
under all treatments. Composition changed significantly across both treatments and time (ANOSIM
p < 0.005 for both factors). HPDI and LPDI seemed to be similar to each other regarding composition
and acidification activity, but different from the control and FOS. FOS differed from the control in
terms of composition but not acidification. HDPI restored alpha-diversity on day 14 as compared to
the control (Bonferroni p < 0.05). In conclusion, the prebiotic activity of fructans appears to depend
on the degree of polymerization, with LPDI and especially HPDI having a greater effect than FOS.
Keywords: prebiotic; inulin-type fructan; fructooligosaccharide; polymerization degree;
metagenomics; microbiome
1. Introduction
It is generally accepted that the bacterial community in the human gastrointestinal tract has a
great impact on intestinal functionality and human health.The colon is the most colonized region
within the gastrointestinal tract, where 1011–1012 cells/mL have been detected [1,2]. The microbes in
our bodies have been estimated to encode 100-fold more unique genes than our own genome [3,4].
High-quality data from the US Human Microbiome Project (HMP) [5], European Metagenomics of the
Human Intestinal Tract (MetaHIT) [6] and several other studies have now demonstrated the beneficial
role of the normal gut microbiota in health down to the genetic level [6,7]. Most bacterial species
colonizing the human gastrointestinal tract belong to the phyla Firmicutes and Bacteroidetes, while
species of the phyla Actinobacteria, Proteobacteria, and Verrucomicrobia exist in lower numbers. The
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number of bacterial species within the human intestinal microbiota has often been estimated to be in
the range of 500 to over 1000 species [8]. In a healthy state, they contribute nutrients and energy to the
host via the fermentation of nondigestible dietary components in the large intestine, and a balance is
maintained with the host’s metabolism and immune system [9,10].
The prebiotic concept was first defined in 1995 as a “non-digestible food ingredient that beneficially
affects the host by selectively stimulating the growth and/or activity of one or a limited number of
bacteria already resident in the colon” [11]. The International Scientific Association for Probiotics
and Prebiotics (ISAPP) recently published a consensus statement to update the definition and scope
of prebiotics. The statement defines a prebiotic as “a substrate that is selectively utilized by host
microorganisms conferring a health benefit” [12]. The scope of this updated definition is therefore
wider, as it implies that the modulatory effect of prebiotics is not necessarily limited to gastrointestinal
microbiota (i.e., it can be administered to microbiota-colonized sites other than the gut). Furthermore,
the ISAPP consensus statement emphasizes that the definition of prebiotics should not be limited to
carbohydrate-based compounds, but should apply to any compound that can be used by the microbiota
to confer a health benefit. Some examples are polyphenols and polyunsaturated fatty acids. The
document also addresses the difficulties involved in providing definitive proof of causality when
assessing the beneficial effects of a prebiotic. Still, it states that the health benefits of a prebiotic must
be confirmed in the target host for its intended use and should always be mediated by the microbiota.
Inulin-type fructans (ITF) are the best-documented oligosaccharides for their effect on intestinal
Bifidobacteria and are considered to be important prebiotic substrates [13]. Fructans can also be
described by their polymerization degree (PD). Inulin-type fructans consisting of DP ≥10 units are
considered long chain, while inulin-type fructans with a DP of <10 are considered short chain [14].
Nutritional studies have recommended a combination of inulins with different chain lengths in order to
maximize their fermentative and prebiotic effects [13]. Beneficial effects of inulin and/or oligofructose
on the intestinal microbiota, have been demonstrated in adults, such as increasing Bifidobacteria and
Lactobacilli, as well as increasing butyrate production [15–17]. Moreover, the prebiotic activity of inulin
and oligofructose seems to translate into beneficial health effects such as improved glycemic control,
reduced plasma triglycerides, improved barrier function, and decreased oxidative stress [14]. However,
not all fructans seem to produce the same effects on the gut microbiota [18–20].
Ex vivo fermentation models are considered reliable tools to assess how microbial populations are
altered by gastrointestinal environments such as prebiotics [21]. The common purpose of ex vivo gut
fermentation models is to cultivate a complex intestinal microbiota under controlled environmental
conditions with the aim of carrying out microbial modulation and metabolism studies. Although
there are several well-studied and validated complex in vitro models of human microbiota (e.g., the
Simulator of the Human Intestinal Microbial Ecosystem (SHIME) [22,23], the TNO Gastrointestinal
Model (TIM-2) [24] and the Three-Stage Compound Continuous Culture System [25], we were interested
in performing a simpler continuous culture system with one single stage.
Several studies have classified the human intestinal microbiota into three enterotypes in order to
reduce the complexity and facilitate the identification of microbiota compositional patterns [26,27]:
enterotype 1, which has Bacteroides as its best indicator; enterotype 2, which is driven by Prevotella, a
genus whose abundance is inversely correlated with Bacteroides; and enterotype 3, which is distinguished
by a significant presence of Firmicutes especially of the Ruminococcus genus [26–28]. However, this
classification should be treated with caution, as some authors have suggested that microbiota could be
divided into two enterotypes, where Bacteroides enterotype was fused with the less well distinguished
Firmicutes enterotype while other authors have proposed four enterotypes, two of theme resembling
previously the described Bacteroides and Prevotella enterotypes, while the other two are a more complex
mixture with lower levels of Bacteroides, one dominated by a variety of populations affiliated within the
Firmicutes phylum and the other combining higher levels of Faecalibacterium and Ruminococcaceae (both
belonging to the Firmicutes phylum) with Alistipes (which belongs to the Bacteroidetes phylum) [28,29].
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The objective of the study was to evaluate how the polymerization degree influences the prebiotic
effect of various fructans (FOS and two inulins with differing degrees of polymerization) in an ex vivo
fermented human microbiome, under conditions that simulated the transverse colon, taken from the
Macfarlane model [25,30].
2. Materials and Methods
2.1. Fructans Analyzed
Three commercial fructans with differing average fructosyl chain lengths (i.e., degree of
polymerization) were chosen for this study.
1. Oligofructose (FOS): Orafti® P95 (BENEO-Orafti S.A., Tienen, Belgium), a short-chain inulin
obtained through partial enzymatic hydrolysis and consisting of fructose units joined by β(2-1)
linkages, with an end-standing glucose unit and an average polymerization degree of two to
eight units.
2. Low-polymerization-degree inulin (LPDI): Orafti® GR (BENEO-Orafti S.A., Tienen, Belgium), a
granulated powder extracted primarily from chicory and consisting of fructose units joined by
β(2-1) linkages, with an end-standing glucose unit and an average polymerization degree of ≥10.
3. High-polymerization-degree inulin (HPDI): Orafti® HPX (BENEO-Orafti S.A., Tienen, Belgium),
a high-performance inulin derived from chicory and consisting of fructose units joined by β(2-1)
linkages, with an end-standing glucose unit and an average polymerization degree of ≥23.
The concentration of each prebiotic in each fermentation vessel was 12 g/L.
2.2. Donor Information
Inclusion criteria of volunteers were as follows: healthy young adults aged 18–30 years, a BMI of
between 19 to 29.9 kg/m2, and type-3 or type-4 stools over the previous 72 h, as per the Bristol stool
scale [31]. Exclusion criteria were as follows: infectious diseases in the three months prior to fecal
donation, antibiotic consumption in the three months prior to donation, blood in the donation, and
alcohol intake 72 h prior to donation. Participants were asked to fill out a 72 h dietary recall form and a
food frequency questionnaire (Supplementary Table S1). Donors were required to consume a varied
diet rich in fruit and vegetables (with a minimum of three portions of vegetables and two portions of
fruit per day).
All subjects gave their informed consent for inclusion before they participated in the study. The
study was conducted in accordance with the Declaration of Helsinki, and the protocol was approved
by the Ethics Committee of the University of Barcelona (IRB00003099).
2.3. Fecal Sample Collection and Inoculum Preparation
Fecal samples were collected (a minimum of 150 g from each donor) and kept in anaerobic
conditions with Oxoid AnaeroGen (Thermo Scientific). The samples were homogenized by dissolution
in glycerol/PBS (10% w/v) directly after collection to maximize preservation for the subsequent stages.
The samples were frozen at−20 ◦C and stored in ready-to-use aliquots in the ex vivo fermentation [32,33].
Prior to fermentation, one aliquot from each donor was incubated for 1 h at 37 ◦C.
2.4. Fermentation
Fermentation was carried out in a single-flow in vitro digestion system that simulated the
transverse colon conditions defined previously [25,30]. The system consisted of eight independent
units (500 mL amber glass jars), in which the fermentation conditions were monitored and controlled.
The pH of the culture medium was maintained at 6.2 ± 0.2 by means of a pH meter (model PH 28,
Crison Instruments S.A., Barcelona, Spain) connected to two peristaltic minipumps (8 RPM, 100 series
pump; Williamson, Southwick, UK) to regulate the addition of HCl 2N or NaOH 3N. Temperature
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was monitored with a probe connected to a digital temperature controller (Autonics, Busan, South
Korea) and maintained at 37 ◦C ± 0.5 with a circulating water bath (PolyScience, Niles, IL, USA).
Anaerobic fermentation conditions were achieved by constant flushing of O2-free N2 gas. Liquid
retention time was 48 h (2.083%/h dilution rate) by means of two precision peristaltic pumps, one for
the culture medium input and one for the fermentation medium output (Masterflex Digital Console
Drive; Cole-Parmer, Vernon Hills, IL, USA). All equipment and consumables used in the fermentation
process were sterilized before the experiment and sampling started.
The artificial colon simulator was fed a complex mixture of nutrients defined by Macfarlane
and widely used in the literature [25,34,35]. This mixture was used as our basal medium, either
supplemented with the fructans or alone as a control. The potentially interesting fructans were tested
after being added to the Macfarlane composition, while the basal medium alone was used as a control
treatment. An aliquot of 60 mL of the prepared fecal inoculum was added to each fermenter, together
with 340 mL of the basal medium. The experiments were carried out in parallel in eight anaerobic jars
(two replicas for each treatment with the basal medium or the basal medium plus fructans).
2.5. Metagenomics Analysis
2.5.1. DNA Extraction
Bacterial DNA was extracted from 0.2 g of each sample using the PowerFecal™ DNA isolation kit
(MO BIO, Carlsbad, CA, USA), in accordance with manufacturer’s instructions. DNA samples (100 µL)
were stored at −20 ◦C until further processing. To assess for contamination from the laboratory or
reagents, blank samples were processed at the same time. Samples obtained from the fermenters were
processed for DNA extraction upon collection.
2.5.2. PCR Amplification and Massive Sequencing
The V4 region of the 16S rRNA gene was amplified with the widely used primer pair F515 (5′-
GTGYCAGCMGCCGCGGTAA-3′) and R806 (5′-GGACTACNVGGGTWTCTAAT-3′). Both primers
included sequencing adaptors at the 5′ end and forward primers were tagged with different barcodes
to pool samples in the same sequencing reaction. The PCR mixture (25 µL) contained 2 µL of DNA
template (5 ng), 5 µL of 5× Phusion® High-Fidelity Buffer, 2.5 µL of dNTPs (2 mM), 0.2 µM of each
primer and 0.5 U of Phusion® Hot Start II Taq Polymerase (Thermo Fisher, Waltham, MA, USA).
The PCR thermal profile consisted of an initial denaturation at 98 ◦C for 30 s, followed by 30 cycles
at 98 ◦C for 15 s, 55 ◦C for 15 s, 72 ◦C at 20 s and a final step at 72 ◦C for 7 min. To assess possible
reagent contamination, each PCR reaction included a no template control (NTC) sample. For each
amplicon, the quality and quantity were assessed with an Agilent 2100 Bioanalyzer and a QubitTM
fluorometer, respectively.
Each sequencing pool included 40 barcoded samples that were sequenced on an Ion Torrent
Personal Genome Machine (PGM) with the Ion 318 Chip Kit v2 and the Ion PGM™ Sequencing 400 Kit
(Life Technologies, Carlsbad, CA, USA), in accordance with manufacturer’s instructions.
2.5.3. Quality Control of the Sequences and OTU Picking
Raw sequencing reads were demultiplexed and quality filtered using QIIME 1.9.1 [36]. The reads
included presented: a length greater than 225 bp; a mean quality score above 25 in a sliding window
of 50 nucleotides; no mismatches on the primer; and default values for other quality parameters.
The quality-filtered reads were subsequently processed with VSEARCH v1.1 pipeline [37]. An initial
dereplication step was applied, then the reads were clustered into operational taxonomic units (OTUs) at
97% similarity with a de novo approach and, finally, de novo chimera checking was performed with the
Uchime function. The raw OTU table was transferred into QIIME 1.9.1 and the taxonomic assignment of
representative OTUs was performed using the Ribosomal Database Project (RDP) Classifier [38] against
the Greengenes v13.8 database [39]. The sequences were aligned with PyNAST [40]. We sequentially
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applied some extra filtering steps in the aligned and taxonomy-assigned OTU table to filter out
sequences belonging to chloroplasts and those belonging to the Shewanellaceae and Halomonadaceae
families, which were represented in the NTC and considered as contamination due to the reagents.
2.5.4. Data Analysis
Data obtained from relative abundance and reads for each sample were organized at the phylum,
class, order, family, and genus levels. The alpha-diversity (within a given sample) was calculated at
the genus level using two indexes: the exponential Shannon index [41] (i.e., the number of effective
OTUs, or Hill number of order 1) and the inverse Simpson index [42] (i.e., the number of highly
effective OTUs, or Hill number of order 2). Two-way analysis of variance (ANOVA) was used to
assess the effect of treatment and time on alpha diversity, community stabilization (i.e., beta-diversity
compared to the previous day) and acidification activity, with the Bonferroni post-test for pairwise
analyses at each time point. The ANOVA was performed and the graphs generated with GraphPad
Prism 5 (GraphPad Software Inc, San Diego, CA, USA). Beta-diversity (among samples, either from
the same or a different treatment) was studied using two types of multivariate analysis at the genus
level: non-metric multidimensional scaling (NMDS) for visual grouping, and analysis of similarities
(ANOSIM) for statistical significance. More precisely, the significance of the effect of the treatment and
time factors was evaluated with two-way ANOSIM, while pairwise differences between treatments
on days 7–14 were evaluated with one-way ANOSIM. This procedure was performed with both the
Sorensen [43] and Bray–Curtis [44] beta-diversity indexes, using the PAST 3.0 program [45].
3. Results
3.1. Relative Abundance
The samples from the three donors (two females and one male aged between 25 and 27) belonged
to the Firmicutes-predominant enterotype according to the MetaHit classifier, and a 1:1:1 mixture was
therefore prepared as an inoculum for all ex vivo experiments.
As expected, the bacterial communities were dominated by the classes Bacilli, Clostridia, and
Erysipelotrichia (all three of which belong to the Firmicutes phylum), Bacteroidia (the Bacteroidetes
phylum), Actinobacteria, and Coriobacteriia (the Actinobacteria phylum) and Betaproteobacteria,
Deltaproteobacteria, and Gammaproteobacteria (Proteobacteria phylum) (Figure 1); Clostridia and
Bacteroidia were the two most abundant classes in the inoculum (Figure 1A).
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Figure 1. Representation of relative abundance to the class level from the initial time, day 2 (D2), day 7
(D7), and day 14 (D14). Assays were: (A) Sample donors; (B) Controls (Cnt.); (C) Fructooligosaccharides
(FOS); (D) Low-polymerization-degree inulin (LPDI); and (E) High-polymerization-degree inulin
(HPDI). Each assay was performed in duplicate.
Under all experimental conditions, Gammaproteobacteria were increased, Clostridia were
moderately reduced, and Betaproteobacteria w e markedly reduc . Coriobact ria, Erys pelotrichia,
Bacilli, and Deltaproteobacteria had minor fluctuations over time, ex ept Erysipelotrichia, that were
moderately increased ith HPDI. Actinobacteria and Bacteroidia continued to be present throughout
the fermentation time, but presen ed considerable fluctuations even among replicat s. The control
treatment (Macfarlane medium withou prebiotic) resulted in the ost consistent growth of Bacteroidia,
while suppl mentation with HPDI resulted in the most st ble abundance of Clos rid a, albeit somewhat
reduced compared to the donor ’ origin l microbiotas (Figure 1).
3.2. Alpha-Diversity
Two indexes to determine diversity were calculated: the exponential Shannon index and the
inverse Simpson index, which correspond to Hill numbers 1 and 2, respectively. Broadly similar trends
were observed in both indexes (Figure 2). Diversity was markedly reduced on day 2, but tended to
stabilization thereafter for most treatments. At the end of the experiment (day 14), HPDI achieved
greater recovery of alp a-diversity, given that it almost reache the initial levels as per the inverse
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Simpson index. LPDI and FOS had lower alpha-diversity, and the control treatment (no prebiotic)
resulted in the lowest alpha-diversity on day 14. A two-way ANOVA analysis with Bonferroni
correction indicated that the only significant pairwise difference was that of HPDI against the control on
day 14 (p < 0.05), while all other pairwise comparisons between groups and days were nonsignificant.
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3.3. Stabilization of the System
Microbiota changes at the genus level over time and within each treatment were studied with the
Sorensen and Bray–Curtis beta-diver ity index s. In ge eral, similarities wi h respect to the previous
ime poi t i creased over time, thus ndicating a more stable compos tion (Figure 3). The l west
similarity was observed between days 0 and 2, thereby indicating a marked compositional departur
from he inoculum. Greater stability was observed for t Sorensen index than for the Bray–Curtis
index, especially on days 2 and 7, hu indicating that the more abundant genera played a mor
significant role in the differences within each treatment over time, as th Bray–Curtis index gives
greater weight to thes genera compared to the Sorensen index. The similarity between days 7 a 14
was the highest for all treatments, which would suggest that the microbial community composition
stabilized, yet a plateau was not observ d within the experimental timeframe. A two-way ANOVA
analysis with Bonferroni correction indic ted that tr atment with FOS resulted in the lowest stabili y n
d 2 (i.e., the large t departure rom the inoculum), as per the Sorensen i dex, compa d to all other
treatments (Bonferroni p < 0.05 for th com ison vs control, HPDI and LPDI). Conv rs ly, HPDI
had a lower stability han all other treatments on day 14, as per the Bray–Curtis index (Bonferroni
p < 0.05 for the comparisons vs control, FOS and LPDI), thereby suggesting that the more bundant
genera had perha s not yet stabilized. All other pairwise comparisons b tween groups and days
we nonsignificant.
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3.4. Similarity Between Treatments
The NMDS analysis revealed a clear closeness between individual donor samples (subsequently
pooled as inoculum), but a cl r separation between the samples and the mic obiotas at day 7 and 14
of ex vivo fermentation, as per both the Sorensen a d Bray–Curtis index s (Figure 4). The Sorensen
index clustered toge her the mic obiotas ferm ted with both the LPDI and HPDI, which were clearly
separated from those ferm nted with FOS or the control medium (no fructan). Conversely, with the
Bray–Curtis index, the microbiotas fermented with FOS remained sepa ated, but the LPDI separa ed
further from the HPDI, while becoming closer to e control co dition. It is worth noting that s mple
separation within HPDI in NMDS analysis was markedly larger with the Bray–Curtis dex than with
the Sorensen one, thus indicating that the variability within HPDI seem to be mostly due to few highly
abundant genera.
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Microbial composition varied significantly both over time and among treatments, as significant
differences were observed upon two-way ANOSIM analysis for the time and treatment factors with
both the Sorensen (p ≤ 0.0001 for both treatment and time) and Bray–Curtis indexes (p = 0.0045 and
p ≤ 0.0001 for treatment and time, respectively). A pairwise comparison between treatments in the
period between days 7 and 14 indicated that the community structure of microbiotas resulting from
fermentation with HPDI or LPDI did not differ significantly from one another, while almost all other
pairwise comparisons resulted in nominally significant differences. More differences were noted with
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the Sorensen index than with the Bray–Curtis index, although none of these significances survived the
Bonferroni correction (Table 1). Of note, NMDS stress factor was below 0.2 both for Bray–Curtis and
Sorensen, indicating that treatment-based clustering was nonrandom.
Table 1. Significance of the differences between treatments based on pooled data from days 7 and 14,
one-way ANOSIM using the Sorensen and Bray–Curtis indexes at the genus level. Reported p-values
are nominal, and none of them held after the Bonferroni correction was applied. vs.—versus.
Sample Sorensen Index (p-Value) Bray–Curtis Index (p-Value)
Sample Donor vs. Control 0.0261 0.0296
Sample Donor vs. FOS 0.0286 0.0285
Sample Donor vs. LPDI 0.0259 0.0301
Sample Donor vs. HPDI 0.0303 0.0290
Control vs. FOS 0.0274 0.0282
Control vs. LPDI 0.0298 0.1477
Control vs. HPDI 0.0283 0.0284
FOS vs. LPDI 0.0308 0.0283
FOS vs. HPDI 0.0282 0.0818
LPDI vs. HPDI 0.2602 0.1952
3.5. pH Variation
Analysis of the differential amount of NaOH and HCl consumed to maintain the fermenter in the
correct pH range (Figure 5) showed that all treatments induced acidification over time (p < 0.0001),
with significant differences among the treatments (p = 0.0012). LPDI and HPDI did not differ from
one another, but clearly produced more acidification than either the control or FOS on days 7 and 14
(Bonferroni post-test p-value < 0.01 for all pairwise comparisons). Note that acidification with FOS
was in fact found to be lower than the control on day 14 (Bonferroni p < 0.05).
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4. Discussion
The health benefits of prebiotics are widely accepted [46], and the present study provides further
evidence that fructan-type prebiotics can modify the human intestinal microbiota. However, fructans
with differing degrees of polymerization (FOS, LPDI, and HPDI) had different impacts on the evolution
of the microbial community.
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Our study used a simple system to simulate average colonic conditions and test the effects
of fructans with different degrees of polymerization in the human gut microbiota. More precisely,
our system corresponded to the transverse colon (middle stage), based on a system developed by
Macfarlane, with pH and retention time conditions similar to the transverse colon conditions in the
SHIME [21]. Conversely, Lacroix [47], with three stages, used a shorter retention time because it
simulated the digestive tract of children. The fermenters were inoculated with pooled fecal material
from three donors belonging to the same Firmicutes enterotype, which has been reported to be the
most common in the population [26]. Moreover, the relative abundances of the microbial communities
in the inocula were similar to those described in the literature for healthy patients [8,26].
This study showed that all alpha-diversity indexes initially decreased in all treatments. Recent
studies that compared the effect of three commercial apple varieties (grated with the skin) versus inulin
and cellulose [48], and the effects of FOS, GOS, XOS, and beta-glucan [49], also showed decreased
alpha-diversity over time for all treatments. This could be a common effect of ex vivo simulation
compared to the real human gut. The results of So et al. 2018 [17] also support the selectivity criteria of
the prebiotic concept, in which the host microorganisms selectively utilize the prebiotic as substrates. It
could be hypothesized that the loss in diversity is due to fructans stimulating just a few bacterial groups,
but our results showed that the control without prebiotic brought about the same behavior, which
would rule out fructans as the cause of diversity loss. The metabolization of dietary polysaccharides
by the gastrointestinal bacteria is an example of the symbiotic relationship between the host and
the microbiota. Furthermore, this relationship provides an avenue for dietary modulation of the
microbiota, because microbial growth and metabolism depend on substrate availability, e.g., the type
of dietary fiber or prebiotic consumed by the host [20]. The Simpson index (i.e., number of highly
effective OTUs) gives more weight to abundant OTUs, compared to the inverse Shannon index (i.e.,
the number of effective OTUs). Our system showed that diversity decreased with both indexes and,
consequently, in both abundant and rare OTUs. Differences among these two indexes showed that
fructans with a higher degree of polymerization (HDPI) produced more diversity towards the end of
the experiment, and that this effect was statistically significant against controls when more weight was
attached to the more abundant (or “highly effective”) OTUs.
Results obtained with our ex vivo fermentation system suggest that the microbiota stabilized from
day 7 of fermentation, as the similarity between days 7 and 14 was found to be high, although a plateau
was not yet reached or not detected. Macfarlane reported that his system stabilized in 24 h, but only
nine bacterial groups where checked with PCR [25]. Conversely, the SHIME takes up to two weeks to
stabilize when 130 different bacterial groups are considered [23], a result much more consistent with
our findings. Greater stability was observed with the Sorensen index compared to Bray–Curtis index,
thus indicating that low-abundance OTUs stabilized faster than highly abundant OTUs, akin to the
behavior of alpha-diversity indexes. Moreover, stability after 14 days of highly abundant OTUs was
significantly lower for long-chain fructans (HPDI) than for all other treatments. Together with the
higher alpha-diversity attained compared to controls, we hypothesize that, given more time, HDPI
could produce an even greater increase in alpha diversity.
As expected, differences in the specific microbiota composition were found among treatment
groups. However, Bonferroni-corrected statistical significance was not attained in pairwise comparisons,
probably owing to the large number of between-group comparisons (six) and the limited number
of replicas.
Taken together, our results show that fructans with a polymerization degree of above 10 (HPDI
and LPDI) result in similar microbiota compositions, especially with respect to low-abundant OTUs,
and in similarly high acidification activity, compared to the control condition (no fructans). Moreover,
the fructan with the highest degree of polymerization (HPDI) restored alpha-diversity to baseline levels
compared to the control when more weight was given to highly abundant OTUs (inverse Simpson
index). These highly abundant OTUs were Bifidobacterium, Bacteroides, Prevotella, Faecalibacterium,
Roseburia, Acidaminococcus, Megasphaera, Catenibacterium, Citrobacter, and three undefined genera
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belonging to the families Enterobacteriaceae, Lachnospiraceae, and Eubacteriaceae. Our observations also
highlight the importance of using different diversity indexes to reveal the differences between more
abundant and less abundant OTUs under a given study factor. Moreover, our experiment showed
that FOS (polymerization degree 2 to 8) promoted a different microbial composition than longer-chain
inulins, and failed to stimulate acidification activity compared to control fermentation without fructans.
Numerous reports link a decreased diversity of the gut microbiota to a declined health status,
including conditions such as inflammatory bowel diseases (ulcerative colitis and Crohn’s disease),
coeliac disease, allergies, and obesity [50]. Recent simulation studies support a causative role of
microbiota diversity in health status [51], and drops in diversity have been associated to a higher risk
of subsequent recurrence both in ulcerative colitis [52,53] and Crohn’s disease [54,55]. Previous studies
in inflammatory bowel disease have used mixtures of low and medium length inulin-type fructans
(i.e., FOS and LDPI) [56]. However, based on our results, HDPI seems a better candidate to promote
microbiota diversity to help prevent recurrence in inflammatory bowel disease, and deserves further
testing in clinical trials.
One of the limitations of our ex vivo model was our use of a single stage of colonic conditions,
corresponding to the transverse colon, rather than multiple stages to simulate the functionality of
different locations in the gut. As fibers are normally degraded in the gut, this factor could introduce
additional differences not observed in this study. A second limitation of our study was the small number
of replicates performed for each treatment, which reduced the statistical power in some analyses. A
third limitation was the fact that the effects of the polymerization degree of fructans were tested on a
microbiota with the Firmicutes-predominant enterotype, and future studies on other enterotypes are
required to compare the results. Any future research should also measure the production of individual
short-chain fatty acids in order to gain further information on the effect of the polymerization degree
on the metabolic activity of the microbiota, which in our study was limited to total acidification activity.
Such research could reveal additional similarities or differences between different fructans. Finally,
it would be especially interesting to study the effect of the degree of polymerization when different
fructans are combined, or even when other types of fiber such as beta-glucans, polydextrose, acacia
gum, pectin, and partially hydrolyzed guar gum are added. The combination of different fibers could
be important to avoid feeding a few bacterial groups, and thus promote a more diverse microbiota [20].
5. Conclusions
In conclusion, the ex vivo system used in our study allowed us to observe the effect of the
degree of polymerization of fructans on the intestinal microbiota. The degree of polymerization of
fructans seems to impact their prebiotic effect, resulting in microbiotas with different compositions.
Higher polymerization seems to facilitate greater diversity and acidification activity compared to
lower polymerization (i.e., FOS), suggesting that inulins of different degree of polymerization produce
different effects on the gut microbiota, both at the compositional and metabolic level. Ultimately,
adequately powered clinical trials should be conducted to confirm these effects in humans.
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